01 1Natco Pharma
01 1IBRUTINIB (IBN)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-09-18
Pay. Date : 2018-08-20
DMF Number : 32937
Submission : 2018-08-17
Status : Active
Type : II
20
Natco Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is IBRUTINIB (IBN), with a corresponding US DMF Number 32937.
Remarkably, this DMF maintains an Active status since its submission on August 17, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 18, 2018, and payment made on August 20, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
